| [1] |
Nova-Camacho LM, Gomez-Dorronsoro M, Guarch R, Cordoba A, Cevallos MI, et al. 2023. Cardiac metastasis from solid cancers: a 35-year single-center autopsy study. |
| [2] |
Maleszewski JJ, Anavekar NS, Moynihan TJ, Klarich KW. 2017. Pathology, imaging, and treatment of cardiac tumours. |
| [3] |
Ciucci G, Lorizio D, Bartoloni N, Budini M, Colliva A, et al. 2026. Mechanical load inhibits cancer growth in mouse and human hearts. |
| [4] |
Zhou ZY, Qin Q, Zhou F, Cao CY, Teng L. 2024. Nesprin proteins: bridging nuclear envelope dynamics to muscular dysfunction. |
| [5] |
Lindenboim L, Zohar H, Gundersen GG, Worman HJ, Stein R. 2024. LINC complex protein nesprin-2 has pro-apoptotic activity via Bcl-2 family proteins. |
| [6] |
Neophytou C, Stylianopoulos T, Mpekris F. 2025. The synergistic potential of mechanotherapy and sonopermeation to enhance cancer treatment effectiveness. |
| [7] |
Jie X, Fong WP, Zhou R, Zhao Y, Zhao Y, et al. 2021. USP9X-mediated KDM4C deubiquitination promotes lung cancer radioresistance by epigenetically inducing TGF-β2 transcription. |
| [8] |
Duan L, Rai G, Roggero C, Zhang QJ, Wei Q, et al. 2015. KDM4/JMJD2 histone demethylase inhibitors block prostate tumor growth by suppressing the expression of AR and BMYB-regulated genes. |
| [9] |
Gray ZH, Honer MA, Ghatalia P, Shi Y, Whetstine JR. 2025. 20 years of histone lysine demethylases: from discovery to the clinic and beyond. |
| [10] |
Young D, Guha C, Sidoli S. 2023. The role of histone H3 lysine demethylases in glioblastoma. |
| [11] |
Monaghan L, Massett ME, Bunschoten RP, Hoose A, Pirvan PA, et al. 2019. The emerging role of H3K9me3 as a potential therapeutic target in acute myeloid leukemia. |
| [12] |
Cursaro I, Milioni L, Eslami K, Sirous H, Carullo G, et al. 2025. Targeting N-methyl-lysine histone demethylase KDM4 in cancer: natural products inhibitors as a driving force for epigenetic drug discovery. |
| [13] |
Yu S, Zhou L, Yang J, Zhang J, Lu W. 2025. Exploring nondegrading molecular glues for protein–protein interactions. |
| [14] |
Wang Y, Barnett SFH, Le S, Guo Z, Zhong X, et al. 2019. Label-free single-molecule quantification of rapamycin-induced FKBP-FRB dimerization for direct control of cellular mechanotransduction. |
| [15] |
Abdel Fattah AR, Kolaitis N, Van Daele K, Daza B, Rustandi AG, et al. 2023. Targeted mechanical stimulation via magnetic nanoparticles guides in vitro tissue development. |
| [16] |
An J, Hong H, Won M, Rha H, Ding Q, et al. 2023. Mechanical stimuli-driven cancer therapeutics. |
| [17] |
Lin G, Du K, Landrowski D, Price RJ, Scott EA. 2025. Ultrasound-responsive nanoparticles: modulating the tumor microenvironment to advance cancer immunotherapy. |
| [18] |
Pacchioni G. 2025. Magnetic microrobots approach the clinic. |
| [19] |
Nikitin AA, Ivanova AV, Semkina AS, Lazareva PA, Abakumov MA. 2022. Magneto-mechanical approach in biomedicine: benefits, challenges, and future perspectives. |